Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Leport

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Cellular and Infection Microbiology|June 26, 2018
<i>Staphylococcus aureus</i> CC30 Lineage and Absence of <i>sed</i>,<i>j</i>,<i>r</i>-Harboring Plasmid Predict Embolism in Infective EndocarditisJean-Philippe Rasigade, Amélie Leclère, François Alla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Health-related quality of life after 1 year of highly active antiretroviral therapyPatrizia Carrieri, Bruno Spire, Ségolène Duran, et al.
Medical Care|February 25, 2012
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipKarine Lamiraud, Jean-Paul Moatti, François Raffi, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2011
Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapyBernard Masquelier, Audrey Taieb, Sandrine Reigadas, et al.
AIDS (London, England)|November 18, 2011
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatmentJacqueline Capeau, Vincent Bouteloup, Christine Katlama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapyXavier Duval, Valérie Journot, Catherine Leport, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 12, 2010
Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelinesCamelia Protopopescu, Perrine Roux, Maria-Patrizia Carrieri, et al.
Antiviral Therapy|May 1, 2012
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapyCamelia Protopopescu, François Raffi, Cécile Brunet-François, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2008
Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapyMarie Préau, Catherine Leport, Virginie Villes, et al.
Stroke|September 19, 2009
Cerebral microbleeds are frequent in infective endocarditis: a case-control studyIsabelle Klein, Bernard Iung, Julien Labreuche, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Cellular and Infection Microbiology|June 26, 2018
<i>Staphylococcus aureus</i> CC30 Lineage and Absence of <i>sed</i>,<i>j</i>,<i>r</i>-Harboring Plasmid Predict Embolism in Infective EndocarditisJean-Philippe Rasigade, Amélie Leclère, François Alla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Health-related quality of life after 1 year of highly active antiretroviral therapyPatrizia Carrieri, Bruno Spire, Ségolène Duran, et al.
Medical Care|February 25, 2012
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipKarine Lamiraud, Jean-Paul Moatti, François Raffi, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2011
Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapyBernard Masquelier, Audrey Taieb, Sandrine Reigadas, et al.
AIDS (London, England)|November 18, 2011
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatmentJacqueline Capeau, Vincent Bouteloup, Christine Katlama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapyXavier Duval, Valérie Journot, Catherine Leport, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 12, 2010
Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelinesCamelia Protopopescu, Perrine Roux, Maria-Patrizia Carrieri, et al.
Antiviral Therapy|May 1, 2012
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapyCamelia Protopopescu, François Raffi, Cécile Brunet-François, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2008
Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapyMarie Préau, Catherine Leport, Virginie Villes, et al.
Stroke|September 19, 2009
Cerebral microbleeds are frequent in infective endocarditis: a case-control studyIsabelle Klein, Bernard Iung, Julien Labreuche, et al.
Pageof 11